Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Rimegepant. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds.
Rimegepant is a medication used for the acute treatment of migraine headaches in adults. Chemically, it is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist. Rimegepant works by blocking the activity of CGRP, a neuropeptide involved in the transmission of pain signals associated with migraines. By inhibiting CGRP receptors, rimegepant helps alleviate migraine symptoms, including pain, nausea, and sensitivity to light and sound. It is available in oral tablet form and is often prescribed for individuals experiencing moderate to severe migraines. As a relatively new class of migraine medications, CGRP antagonists like rimegepant provide an alternative for those who may not tolerate or respond well to other migraine treatments. The use of rimegepant is typically guided by healthcare professionals based on the specific needs and medical history of the patient.
Buy high quality N-Nitroso Rimegepant Impurity 1 from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of N-Nitroso Rimegepant Impurity 1

N-Nitroso Rimegepant Impurity 1

CAT. No. CP-R34004
CAS. No. NA
Mol. F. C15H23N5O3
Mol. Wt. 321.38
Stock Status Please Enquire
VIEW COA Sample PDF

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:Tert-butyl 4-((2-aminopyridin-3-yl)(nitroso)amino)piperidine-1-carboxylate

Request for Quotation : N-Nitroso Rimegepant Impurity 1

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...